Parkinson’s disease and COVID-19: treatment and patient management during a pandemic

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Bibliographic Details
Main Author:	Afsana, Nourin
Other Authors:	Alam, Marzia
Format:	Thesis
Language:	English
Published:	Brac University 2022
Subjects:	Covid-19 Parkinson's disease Antibodies Anosmia Amantadine Lockdown COVID-19 (Disease) > Treatment
Online Access:	http://hdl.handle.net/10361/17186

id	10361-17186
record_format	dspace
spelling	10361-171862022-09-11T21:01:36Z Parkinson’s disease and COVID-19: treatment and patient management during a pandemic Afsana, Nourin Alam, Marzia Department of Pharmacy, Brac University Covid-19 Parkinson's disease Antibodies Anosmia Amantadine Lockdown Parkinson's disease COVID-19 (Disease)--Treatment This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. Cataloged from PDF version of thesis report. Includes bibliographical references (pages 31-46). One of the most remarkable health problems we have faced since the World War II is the COVID-19 outbreak. This review article discusses insights from basic science as well as clinical perspectives on COVID-19 disease with a specific concern on Parkinson’s disease (PD). Patients with COVID-19 have compromised immunity, especially in an aged population suffering from PD. The 1st report on the relationship between COVID-19 and PD comes from the research on antibodies against four antigens of COVID-19 in Cerebrospinal Fluid (CSF) of normal controls compared to patients with neurological illnesses, especially PD. Unfortunately, identification of COVID-19 is difficult in PD patients because PD is often preceded by anosmia, which is a common feature of COVID-19. Presently, no disease-modifying treatment is available for PD. But for temporary relief, the treatment is composed of dopaminergic drugs like levodopa and PD patients with COVID-19 are treated with favipiravir, amantadine etc. where amantadine was the first FDA-approved medicine in the United States that indicates dual function in the treatment of both diseases. This review also discusses the COVID-19 negative impact on PD patients due to lockdown/isolation. To conclude, this review is mainly focused on the COVID-19 and PD relationship, consequences of PD patients infected with COVID-19, treatment options and COVID-19 impact on PD patients. Nourin Afsana B. Pharmacy 2022-09-11T04:19:59Z 2022-09-11T04:19:59Z 2021 2021-09 Thesis ID 16346053 http://hdl.handle.net/10361/17186 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 46 pages application/pdf Brac University
institution	Brac University
collection	Institutional Repository
language	English
topic	Covid-19 Parkinson's disease Antibodies Anosmia Amantadine Lockdown Parkinson's disease COVID-19 (Disease)--Treatment
spellingShingle	Covid-19 Parkinson's disease Antibodies Anosmia Amantadine Lockdown Parkinson's disease COVID-19 (Disease)--Treatment Afsana, Nourin Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
description	This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
author2	Alam, Marzia
author_facet	Alam, Marzia Afsana, Nourin
format	Thesis
author	Afsana, Nourin
author_sort	Afsana, Nourin
title	Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
title_short	Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
title_full	Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
title_fullStr	Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
title_full_unstemmed	Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
title_sort	parkinson’s disease and covid-19: treatment and patient management during a pandemic
publisher	Brac University
publishDate	2022
url	http://hdl.handle.net/10361/17186
work_keys_str_mv	AT afsananourin parkinsonsdiseaseandcovid19treatmentandpatientmanagementduringapandemic
_version_	1814308328973533184

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic

Similar Items